IL-6/STAT-3 inhibitors (Cancer Research UK/University of London/UCL)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameIL-6/STAT-3 inhibitors (Cancer Research UK/University of London/UCL)
Drug Alias NameRH-06
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIL-6 receptor antagonistsSignal transducer and activator of transcription 3 inhibitors
TargetsIL-6 receptorSignal transducer and activator of transcription 3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCancer Research UK
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity College London Hospitals Nhs Foundation TrustCancer Research UKUniversity Of London
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A